KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
8.36
+0.27 (3.34%)
At close: Dec 20, 2024, 4:00 PM
8.50
+0.14 (1.67%)
After-hours: Dec 20, 2024, 7:57 PM EST
KalVista Pharmaceuticals Employees
KalVista Pharmaceuticals had 150 employees as of April 30, 2024. The number of employees increased by 32 or 27.12% compared to the previous year.
Employees
150
Change (1Y)
32
Growth (1Y)
27.12%
Revenue / Employee
n/a
Profits / Employee
-$1,042,580
Market Cap
413.13M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Community Health Systems | 61,000 |
| Enhabit | 10,800 |
| National Research | 435 |
| Allogene Therapeutics | 233 |
| Alpha Teknova | 211 |
| Arcturus Therapeutics Holdings | 180 |
| Akebia Therapeutics | 167 |
| Nano-X Imaging | 164 |
KALV News
- 3 days ago - KalVista: Potential First With Multiple Sebetralstat Regulatory Reviews In 2025 - Seeking Alpha
- 5 days ago - KalVista Appoints Jeb Ledell as Chief Operating Officer - Business Wire
- 16 days ago - KalVista Pharmaceuticals Reports Second Fiscal Quarter Results and Provides Operational Update - Business Wire
- 17 days ago - KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 25 days ago - KalVista Pharmaceuticals Appoints Laurence Reid, Ph.D., to Board of Directors - Business Wire
- 5 weeks ago - KalVista Pharmaceuticals to Present at Upcoming Investor Conferences - Business Wire
- 6 weeks ago - KalVista Pharmaceuticals Announces Pricing of a $55 Million Underwritten Offering of Common Stock and Concurrent Private Placement of $5 Million - Business Wire
- 6 weeks ago - KalVista Pharmaceuticals Enters into Non-Dilutive Synthetic Royalty Financing with DRI Healthcare Trust - Business Wire